Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 7.34486655 |
2 | omega-hydroxylase P450 pathway (GO:0097267) | 7.09242154 |
3 | epoxygenase P450 pathway (GO:0019373) | 6.91065872 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.79670874 |
5 | L-phenylalanine catabolic process (GO:0006559) | 6.79670874 |
6 | * acute-phase response (GO:0006953) | 6.75188972 |
7 | regulation of protein activation cascade (GO:2000257) | 6.68935683 |
8 | L-phenylalanine metabolic process (GO:0006558) | 6.56426715 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.56426715 |
10 | complement activation, alternative pathway (GO:0006957) | 6.37091738 |
11 | negative regulation of fibrinolysis (GO:0051918) | 6.36590870 |
12 | aromatic amino acid family catabolic process (GO:0009074) | 6.34417158 |
13 | indole-containing compound catabolic process (GO:0042436) | 6.15821669 |
14 | indolalkylamine catabolic process (GO:0046218) | 6.15821669 |
15 | tryptophan catabolic process (GO:0006569) | 6.15821669 |
16 | regulation of complement activation (GO:0030449) | 6.03917412 |
17 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 6.01865486 |
18 | regulation of fibrinolysis (GO:0051917) | 6.00493535 |
19 | heme transport (GO:0015886) | 5.99813320 |
20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.99094291 |
21 | kynurenine metabolic process (GO:0070189) | 5.96677985 |
22 | protein carboxylation (GO:0018214) | 5.85648373 |
23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.85648373 |
24 | tryptophan metabolic process (GO:0006568) | 5.67980270 |
25 | high-density lipoprotein particle remodeling (GO:0034375) | 5.53860470 |
26 | ethanol oxidation (GO:0006069) | 5.49397345 |
27 | opsonization (GO:0008228) | 5.37585963 |
28 | bile acid biosynthetic process (GO:0006699) | 5.29135249 |
29 | negative regulation of protein activation cascade (GO:2000258) | 5.29064130 |
30 | glyoxylate metabolic process (GO:0046487) | 5.25600856 |
31 | urea cycle (GO:0000050) | 5.22906680 |
32 | urea metabolic process (GO:0019627) | 5.22906680 |
33 | regulation of cholesterol esterification (GO:0010872) | 5.22162118 |
34 | drug metabolic process (GO:0017144) | 5.09936167 |
35 | regulation of triglyceride catabolic process (GO:0010896) | 5.07348596 |
36 | alpha-linolenic acid metabolic process (GO:0036109) | 4.98039426 |
37 | phospholipid efflux (GO:0033700) | 4.85003574 |
38 | macromolecular complex remodeling (GO:0034367) | 4.77817265 |
39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.77817265 |
40 | protein-lipid complex remodeling (GO:0034368) | 4.77817265 |
41 | nitrogen cycle metabolic process (GO:0071941) | 4.76243510 |
42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.74809508 |
43 | reverse cholesterol transport (GO:0043691) | 4.70526762 |
44 | complement activation, classical pathway (GO:0006958) | 4.61566467 |
45 | fibrinolysis (GO:0042730) | 4.56417496 |
46 | aromatic amino acid family metabolic process (GO:0009072) | 4.54346455 |
47 | * acute inflammatory response (GO:0002526) | 4.48466330 |
48 | ethanol metabolic process (GO:0006067) | 4.46721863 |
49 | cysteine metabolic process (GO:0006534) | 4.46689513 |
50 | oxidative demethylation (GO:0070989) | 4.44326489 |
51 | negative regulation of cholesterol transport (GO:0032375) | 4.42004582 |
52 | negative regulation of sterol transport (GO:0032372) | 4.42004582 |
53 | cellular glucuronidation (GO:0052695) | 4.39421565 |
54 | bile acid metabolic process (GO:0008206) | 4.39157635 |
55 | complement activation (GO:0006956) | 4.38135842 |
56 | triglyceride homeostasis (GO:0070328) | 4.36655532 |
57 | acylglycerol homeostasis (GO:0055090) | 4.36655532 |
58 | sulfur amino acid catabolic process (GO:0000098) | 4.36528096 |
59 | serine family amino acid catabolic process (GO:0009071) | 4.35303203 |
60 | protein activation cascade (GO:0072376) | 4.34707653 |
61 | iron coordination entity transport (GO:1901678) | 4.34359810 |
62 | response to phenylpropanoid (GO:0080184) | 4.29438092 |
63 | triglyceride catabolic process (GO:0019433) | 4.27489877 |
64 | coenzyme catabolic process (GO:0009109) | 4.26543701 |
65 | plasma lipoprotein particle clearance (GO:0034381) | 4.25510076 |
66 | cholesterol efflux (GO:0033344) | 4.24909323 |
67 | indolalkylamine metabolic process (GO:0006586) | 4.21742176 |
68 | benzene-containing compound metabolic process (GO:0042537) | 4.19482888 |
69 | cellular biogenic amine catabolic process (GO:0042402) | 4.18396354 |
70 | amine catabolic process (GO:0009310) | 4.18396354 |
71 | tyrosine metabolic process (GO:0006570) | 4.16819519 |
72 | glucuronate metabolic process (GO:0019585) | 4.16632103 |
73 | uronic acid metabolic process (GO:0006063) | 4.16632103 |
74 | regulation of humoral immune response (GO:0002920) | 4.15118724 |
75 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.14280075 |
76 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.14280075 |
77 | lysine catabolic process (GO:0006554) | 4.12468445 |
78 | lysine metabolic process (GO:0006553) | 4.12468445 |
79 | cytolysis (GO:0019835) | 4.10202290 |
80 | regulation of plasminogen activation (GO:0010755) | 4.08806978 |
81 | plasma lipoprotein particle assembly (GO:0034377) | 4.04053012 |
82 | alpha-amino acid catabolic process (GO:1901606) | 4.02478578 |
83 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.99615132 |
84 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.99615132 |
85 | negative regulation of complement activation (GO:0045916) | 3.98824441 |
86 | blood coagulation, intrinsic pathway (GO:0007597) | 3.97409226 |
87 | negative regulation of lipase activity (GO:0060192) | 3.93390101 |
88 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.91393331 |
89 | acylglycerol catabolic process (GO:0046464) | 3.90598887 |
90 | neutral lipid catabolic process (GO:0046461) | 3.90598887 |
91 | homocysteine metabolic process (GO:0050667) | 3.83319610 |
92 | phenylpropanoid metabolic process (GO:0009698) | 3.80489829 |
93 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.80454619 |
94 | cofactor catabolic process (GO:0051187) | 3.79658485 |
95 | positive regulation of lipid catabolic process (GO:0050996) | 3.79463245 |
96 | amino-acid betaine metabolic process (GO:0006577) | 3.78988483 |
97 | bile acid and bile salt transport (GO:0015721) | 3.76990579 |
98 | negative regulation of coagulation (GO:0050819) | 3.76985749 |
99 | glutamate metabolic process (GO:0006536) | 3.69712693 |
100 | regulation of cholesterol homeostasis (GO:2000188) | 3.69320032 |
101 | negative regulation of wound healing (GO:0061045) | 3.66830817 |
102 | S-adenosylmethionine metabolic process (GO:0046500) | 3.66763503 |
103 | arginine metabolic process (GO:0006525) | 3.64905856 |
104 | cellular amino acid catabolic process (GO:0009063) | 3.63872910 |
105 | regulation of acute inflammatory response (GO:0002673) | 3.63432326 |
106 | protein-lipid complex assembly (GO:0065005) | 3.63021284 |
107 | cellular modified amino acid catabolic process (GO:0042219) | 3.62054782 |
108 | drug catabolic process (GO:0042737) | 3.61461859 |
109 | plasma lipoprotein particle organization (GO:0071827) | 3.60549244 |
110 | glycine metabolic process (GO:0006544) | 3.56394580 |
111 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.55582234 |
112 | low-density lipoprotein particle clearance (GO:0034383) | 3.54876100 |
113 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.53637340 |
114 | regulation of apoptotic cell clearance (GO:2000425) | 3.51864153 |
115 | serine family amino acid metabolic process (GO:0009069) | 3.51291288 |
116 | imidazole-containing compound metabolic process (GO:0052803) | 3.49648562 |
117 | acetyl-CoA metabolic process (GO:0006084) | 3.47084084 |
118 | negative regulation of hemostasis (GO:1900047) | 3.45484874 |
119 | negative regulation of blood coagulation (GO:0030195) | 3.45484874 |
120 | disruption of cells of other organism (GO:0044364) | 3.45408544 |
121 | killing of cells of other organism (GO:0031640) | 3.45408544 |
122 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.44931222 |
123 | flavonoid metabolic process (GO:0009812) | 3.44906239 |
124 | primary alcohol metabolic process (GO:0034308) | 3.43588530 |
125 | lipoprotein metabolic process (GO:0042157) | 3.42504592 |
126 | cholesterol homeostasis (GO:0042632) | 3.42008325 |
127 | primary alcohol catabolic process (GO:0034310) | 3.40348385 |
128 | oxaloacetate metabolic process (GO:0006107) | 3.29299741 |
129 | doxorubicin metabolic process (GO:0044598) | 3.26540271 |
130 | daunorubicin metabolic process (GO:0044597) | 3.26540271 |
131 | polyketide metabolic process (GO:0030638) | 3.26540271 |
132 | positive regulation of blood coagulation (GO:0030194) | 3.25161563 |
133 | positive regulation of hemostasis (GO:1900048) | 3.25161563 |
134 | intestinal cholesterol absorption (GO:0030299) | 3.22429063 |
135 | negative regulation of humoral immune response (GO:0002921) | 3.20853072 |
136 | arginine catabolic process (GO:0006527) | 3.17381101 |
137 | fatty acid homeostasis (GO:0055089) | 3.14674957 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.74728315 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.74061925 |
3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.73229256 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.01637568 |
5 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.48454062 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.33541496 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.03136229 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.39143874 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.35461749 |
10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.04256469 |
11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03833617 |
12 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7187876 |
13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.99883627 |
14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.93296014 |
15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.87701545 |
16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.81762610 |
17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.80931708 |
18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.78731160 |
19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67089200 |
20 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61089162 |
21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47646782 |
22 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.45605457 |
23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39724729 |
24 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33449512 |
25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.26590132 |
26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.22099578 |
27 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18717296 |
28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13109771 |
29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11222740 |
30 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.10822438 |
31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.09455136 |
32 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06553901 |
33 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04680489 |
34 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02628654 |
35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.00815659 |
36 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97254850 |
37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96151819 |
38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93417455 |
39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93403688 |
40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92325785 |
41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.90780624 |
42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89917588 |
43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87464518 |
44 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.84898844 |
45 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83601659 |
46 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80898972 |
47 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80032895 |
48 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.78881421 |
49 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.77410144 |
50 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.74371424 |
51 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72117385 |
52 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.71631138 |
53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.71564001 |
54 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.70158266 |
55 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.69119185 |
56 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.68194447 |
57 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.67407806 |
58 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.67354908 |
59 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.67260625 |
60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66329933 |
61 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66131515 |
62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66131515 |
63 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.65220597 |
64 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.64957267 |
65 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.63503130 |
66 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.63503130 |
67 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.62474978 |
68 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.62168175 |
69 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.62127330 |
70 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.61767817 |
71 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.60105806 |
72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.60102657 |
73 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.59088865 |
74 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.58345100 |
75 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58219027 |
76 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57611921 |
77 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.57599567 |
78 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.57187546 |
79 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.56799827 |
80 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.56595250 |
81 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.55580495 |
82 | ERA_21632823_ChIP-Seq_H3396_Human | 0.55341119 |
83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.54695058 |
84 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.54625366 |
85 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.54583019 |
86 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.54464996 |
87 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.53695905 |
88 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.53020048 |
89 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52809034 |
90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.52494871 |
91 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.51937298 |
92 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.51302673 |
93 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.51195374 |
94 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.50990921 |
95 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.50493903 |
96 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.50461576 |
97 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.49640331 |
98 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.49456613 |
99 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.49087864 |
100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.48993101 |
101 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.48945376 |
102 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47651017 |
103 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.47212969 |
104 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45520078 |
105 | AR_20517297_ChIP-Seq_VCAP_Human | 0.44743975 |
106 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.44706657 |
107 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.44421291 |
108 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.43813739 |
109 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.43520877 |
110 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.42446282 |
111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42436340 |
112 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42245322 |
113 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.41846965 |
114 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.41212642 |
115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.41155193 |
116 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.40876487 |
117 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.40183106 |
118 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.40093571 |
119 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.40013746 |
120 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.39689143 |
121 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.39301164 |
122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.39033425 |
123 | GATA1_19941826_ChIP-Seq_K562_Human | 0.38771965 |
124 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.38569047 |
125 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.38067120 |
126 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.37565041 |
127 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.37461730 |
128 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.37178622 |
129 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.36499753 |
130 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.35767668 |
131 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.35114839 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.00007470 |
2 | MP0005360_urolithiasis | 7.58562685 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.21539955 |
4 | MP0005365_abnormal_bile_salt | 5.85868522 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.42510300 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.05539483 |
7 | MP0010329_abnormal_lipoprotein_level | 3.52488640 |
8 | MP0003252_abnormal_bile_duct | 3.43102208 |
9 | MP0003191_abnormal_cellular_cholesterol | 3.35199248 |
10 | MP0009840_abnormal_foam_cell | 3.23548629 |
11 | MP0005083_abnormal_biliary_tract | 2.94602285 |
12 | MP0003195_calcinosis | 2.65332554 |
13 | MP0005332_abnormal_amino_acid | 2.64237777 |
14 | MP0001666_abnormal_nutrient_absorption | 2.50747266 |
15 | MP0000609_abnormal_liver_physiology | 2.17584358 |
16 | * MP0002118_abnormal_lipid_homeostasis | 2.07361843 |
17 | MP0004019_abnormal_vitamin_homeostasis | 1.92621880 |
18 | MP0002138_abnormal_hepatobiliary_system | 1.91313583 |
19 | MP0005319_abnormal_enzyme/_coenzyme | 1.78332474 |
20 | MP0003011_delayed_dark_adaptation | 1.74921560 |
21 | MP0005375_adipose_tissue_phenotype | 1.74280340 |
22 | MP0000604_amyloidosis | 1.61853504 |
23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53459062 |
24 | MP0003705_abnormal_hypodermis_morpholog | 1.41876990 |
25 | MP0001764_abnormal_homeostasis | 1.39754180 |
26 | MP0003868_abnormal_feces_composition | 1.38748925 |
27 | MP0002254_reproductive_system_inflammat | 1.37755212 |
28 | MP0009643_abnormal_urine_homeostasis | 1.32907958 |
29 | MP0009764_decreased_sensitivity_to | 1.31048330 |
30 | MP0009697_abnormal_copulation | 1.30366201 |
31 | MP0001881_abnormal_mammary_gland | 1.25412898 |
32 | MP0009763_increased_sensitivity_to | 1.23721734 |
33 | MP0005636_abnormal_mineral_homeostasis | 1.19685010 |
34 | MP0003656_abnormal_erythrocyte_physiolo | 1.16339675 |
35 | MP0002132_abnormal_respiratory_system | 1.14898009 |
36 | MP0005670_abnormal_white_adipose | 1.13873104 |
37 | MP0010368_abnormal_lymphatic_system | 1.13061702 |
38 | MP0000598_abnormal_liver_morphology | 1.12819983 |
39 | MP0008469_abnormal_protein_level | 1.11960680 |
40 | MP0005647_abnormal_sex_gland | 1.08083481 |
41 | MP0003690_abnormal_glial_cell | 1.00054618 |
42 | MP0003959_abnormal_lean_body | 0.98713184 |
43 | MP0000003_abnormal_adipose_tissue | 0.96852637 |
44 | * MP0009642_abnormal_blood_homeostasis | 0.94190609 |
45 | MP0003950_abnormal_plasma_membrane | 0.92614213 |
46 | MP0003186_abnormal_redox_activity | 0.91647807 |
47 | MP0009379_abnormal_foot_pigmentation | 0.89041891 |
48 | MP0005464_abnormal_platelet_physiology | 0.86909280 |
49 | MP0004272_abnormal_basement_membrane | 0.85589266 |
50 | MP0004185_abnormal_adipocyte_glucose | 0.83948223 |
51 | MP0002971_abnormal_brown_adipose | 0.81862665 |
52 | MP0000579_abnormal_nail_morphology | 0.81328986 |
53 | MP0009765_abnormal_xenobiotic_induced | 0.81249618 |
54 | MP0009053_abnormal_anal_canal | 0.80378869 |
55 | MP0009384_cardiac_valve_regurgitation | 0.79864081 |
56 | MP0010234_abnormal_vibrissa_follicle | 0.77850308 |
57 | MP0005220_abnormal_exocrine_pancreas | 0.75694645 |
58 | MP0003724_increased_susceptibility_to | 0.74346895 |
59 | MP0005084_abnormal_gallbladder_morpholo | 0.74067525 |
60 | MP0002282_abnormal_trachea_morphology | 0.74051523 |
61 | MP0003329_amyloid_beta_deposits | 0.72805297 |
62 | MP0005376_homeostasis/metabolism_phenot | 0.71981592 |
63 | MP0004264_abnormal_extraembryonic_tissu | 0.69895899 |
64 | MP0005451_abnormal_body_composition | 0.69802995 |
65 | MP0002078_abnormal_glucose_homeostasis | 0.69748668 |
66 | MP0005334_abnormal_fat_pad | 0.69469075 |
67 | MP0003879_abnormal_hair_cell | 0.69206168 |
68 | MP0005023_abnormal_wound_healing | 0.69140030 |
69 | MP0005408_hypopigmentation | 0.69106735 |
70 | MP0004130_abnormal_muscle_cell | 0.68466488 |
71 | MP0005395_other_phenotype | 0.67460507 |
72 | MP0005166_decreased_susceptibility_to | 0.67419657 |
73 | MP0003436_decreased_susceptibility_to | 0.65830105 |
74 | MP0000639_abnormal_adrenal_gland | 0.65772488 |
75 | MP0006138_congestive_heart_failure | 0.65274669 |
76 | MP0002909_abnormal_adrenal_gland | 0.64770152 |
77 | MP0001879_abnormal_lymphatic_vessel | 0.64629465 |
78 | MP0002876_abnormal_thyroid_physiology | 0.62288649 |
79 | MP0006036_abnormal_mitochondrial_physio | 0.62180113 |
80 | MP0005452_abnormal_adipose_tissue | 0.61627394 |
81 | MP0005535_abnormal_body_temperature | 0.58041369 |
82 | MP0003075_altered_response_to | 0.57937761 |
83 | MP0005666_abnormal_adipose_tissue | 0.57407252 |
84 | MP0008872_abnormal_physiological_respon | 0.57331846 |
85 | MP0002136_abnormal_kidney_physiology | 0.56789019 |
86 | MP0004043_abnormal_pH_regulation | 0.55097478 |
87 | MP0008873_increased_physiological_sensi | 0.54415985 |
88 | MP0009780_abnormal_chondrocyte_physiolo | 0.53384289 |
89 | MP0002796_impaired_skin_barrier | 0.53249367 |
90 | MP0005503_abnormal_tendon_morphology | 0.52336071 |
91 | MP0002295_abnormal_pulmonary_circulatio | 0.52129350 |
92 | MP0008438_abnormal_cutaneous_collagen | 0.51910041 |
93 | MP0001756_abnormal_urination | 0.49334987 |
94 | MP0002108_abnormal_muscle_morphology | 0.48777556 |
95 | MP0001661_extended_life_span | 0.48602266 |
96 | MP0008874_decreased_physiological_sensi | 0.48470341 |
97 | MP0005595_abnormal_vascular_smooth | 0.48145884 |
98 | MP0000858_altered_metastatic_potential | 0.47646832 |
99 | MP0002249_abnormal_larynx_morphology | 0.47294097 |
100 | MP0005275_abnormal_skin_tensile | 0.47048695 |
101 | MP0003638_abnormal_response/metabolism_ | 0.46754475 |
102 | MP0002332_abnormal_exercise_endurance | 0.46485848 |
103 | MP0000013_abnormal_adipose_tissue | 0.46138887 |
104 | MP0005266_abnormal_metabolism | 0.46069354 |
105 | MP0003828_pulmonary_edema | 0.45907118 |
106 | MP0005448_abnormal_energy_balance | 0.43445742 |
107 | MP0002168_other_aberrant_phenotype | 0.43187014 |
108 | MP0001944_abnormal_pancreas_morphology | 0.43138097 |
109 | MP0003453_abnormal_keratinocyte_physiol | 0.43060708 |
110 | MP0003303_peritoneal_inflammation | 0.41961031 |
111 | MP0009785_altered_susceptibility_to | 0.40851050 |
112 | MP0003300_gastrointestinal_ulcer | 0.40506512 |
113 | MP0001845_abnormal_inflammatory_respons | 0.39741490 |
114 | MP0005164_abnormal_response_to | 0.39706085 |
115 | MP0000427_abnormal_hair_cycle | 0.38373402 |
116 | MP0002135_abnormal_kidney_morphology | 0.37786544 |
117 | MP0006082_CNS_inflammation | 0.36001078 |
118 | MP0000249_abnormal_blood_vessel | 0.34704064 |
119 | MP0009115_abnormal_fat_cell | 0.34526806 |
120 | MP0003953_abnormal_hormone_level | 0.33715106 |
121 | MP0002060_abnormal_skin_morphology | 0.31643444 |
122 | MP0002970_abnormal_white_adipose | 0.31626695 |
123 | MP0006035_abnormal_mitochondrial_morpho | 0.31475986 |
124 | MP0005248_abnormal_Harderian_gland | 0.30370562 |
125 | MP0003718_maternal_effect | 0.30136064 |
126 | MP0000467_abnormal_esophagus_morphology | 0.28336767 |
127 | MP0004883_abnormal_blood_vessel | 0.28311062 |
128 | MP0003633_abnormal_nervous_system | 0.27114538 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.43902763 |
2 | Complement deficiency (HP:0004431) | 7.22367370 |
3 | Prolonged partial thromboplastin time (HP:0003645) | 6.95066624 |
4 | Intrahepatic cholestasis (HP:0001406) | 6.61589729 |
5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.50986821 |
6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.34585471 |
7 | Abnormality of the common coagulation pathway (HP:0010990) | 6.32440184 |
8 | Spontaneous abortion (HP:0005268) | 6.32270821 |
9 | Xanthomatosis (HP:0000991) | 5.79985052 |
10 | Hypobetalipoproteinemia (HP:0003563) | 5.59016227 |
11 | Hyperlipoproteinemia (HP:0010980) | 5.58317948 |
12 | Abnormality of complement system (HP:0005339) | 5.29527884 |
13 | Joint hemorrhage (HP:0005261) | 5.19236602 |
14 | Hypolipoproteinemia (HP:0010981) | 4.40994571 |
15 | Epidermoid cyst (HP:0200040) | 4.26025366 |
16 | Abnormality of the intrinsic pathway (HP:0010989) | 4.18548218 |
17 | Hypoalphalipoproteinemia (HP:0003233) | 4.12733753 |
18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.11666384 |
19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.04662263 |
20 | Hyperammonemia (HP:0001987) | 4.00678999 |
21 | Gingival bleeding (HP:0000225) | 3.98510427 |
22 | Fat malabsorption (HP:0002630) | 3.93868977 |
23 | Amyloidosis (HP:0011034) | 3.83137939 |
24 | Hyperglycinemia (HP:0002154) | 3.80991809 |
25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.80644012 |
26 | Ketosis (HP:0001946) | 3.75605699 |
27 | Abnormality of methionine metabolism (HP:0010901) | 3.71463009 |
28 | Hypoglycemic coma (HP:0001325) | 3.71071451 |
29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.68935407 |
30 | Systemic lupus erythematosus (HP:0002725) | 3.63728207 |
31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.51040744 |
32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.30863612 |
33 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.24502051 |
34 | Hypercholesterolemia (HP:0003124) | 3.23449648 |
35 | Myocardial infarction (HP:0001658) | 3.17594658 |
36 | Abnormality of glycine metabolism (HP:0010895) | 3.15934625 |
37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.15934625 |
38 | Hyperglycinuria (HP:0003108) | 3.05587771 |
39 | Steatorrhea (HP:0002570) | 3.04571555 |
40 | Thrombophlebitis (HP:0004418) | 3.01767191 |
41 | Glomerulonephritis (HP:0000099) | 3.00396285 |
42 | Abnormality of nucleobase metabolism (HP:0010932) | 2.97648273 |
43 | Abnormality of iron homeostasis (HP:0011031) | 2.95019610 |
44 | Ketoacidosis (HP:0001993) | 2.82058323 |
45 | Hyperbilirubinemia (HP:0002904) | 2.81895091 |
46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.79044968 |
47 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.77348190 |
48 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.75513194 |
49 | Abnormality of purine metabolism (HP:0004352) | 2.70952037 |
50 | Skin nodule (HP:0200036) | 2.70288291 |
51 | Hypochromic microcytic anemia (HP:0004840) | 2.65853053 |
52 | Hypoglycemic seizures (HP:0002173) | 2.61765342 |
53 | Mitral stenosis (HP:0001718) | 2.57827329 |
54 | Hepatocellular carcinoma (HP:0001402) | 2.54403747 |
55 | Spastic diplegia (HP:0001264) | 2.53226003 |
56 | Joint swelling (HP:0001386) | 2.51470253 |
57 | Vascular calcification (HP:0004934) | 2.51054627 |
58 | Late onset (HP:0003584) | 2.47889877 |
59 | Abnormality of serum amino acid levels (HP:0003112) | 2.45371449 |
60 | Oligomenorrhea (HP:0000876) | 2.39394397 |
61 | Cholecystitis (HP:0001082) | 2.39192844 |
62 | Abnormal gallbladder physiology (HP:0012438) | 2.39192844 |
63 | Nephritis (HP:0000123) | 2.38887746 |
64 | Acanthosis nigricans (HP:0000956) | 2.38126190 |
65 | Delayed CNS myelination (HP:0002188) | 2.33671134 |
66 | Increased serum pyruvate (HP:0003542) | 2.33663097 |
67 | Menorrhagia (HP:0000132) | 2.31811941 |
68 | Cholelithiasis (HP:0001081) | 2.30892574 |
69 | Lethargy (HP:0001254) | 2.29370042 |
70 | Abnormal gallbladder morphology (HP:0012437) | 2.28002239 |
71 | Gout (HP:0001997) | 2.25891752 |
72 | Cardiovascular calcification (HP:0011915) | 2.25187189 |
73 | Generalized aminoaciduria (HP:0002909) | 2.24848743 |
74 | Metabolic acidosis (HP:0001942) | 2.23323748 |
75 | Irritability (HP:0000737) | 2.22533736 |
76 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.20751130 |
77 | Esophageal varix (HP:0002040) | 2.19002402 |
78 | Abnormal delivery (HP:0001787) | 2.17632891 |
79 | Neonatal onset (HP:0003623) | 2.14971896 |
80 | Purpura (HP:0000979) | 2.14584063 |
81 | Sensorimotor neuropathy (HP:0007141) | 2.12873090 |
82 | Reduced antithrombin III activity (HP:0001976) | 2.10223537 |
83 | Malnutrition (HP:0004395) | 2.09896737 |
84 | Epistaxis (HP:0000421) | 2.06869221 |
85 | Abnormality of proline metabolism (HP:0010907) | 2.02146580 |
86 | Hydroxyprolinuria (HP:0003080) | 2.02146580 |
87 | Cerebral edema (HP:0002181) | 1.99972425 |
88 | Neonatal hypoglycemia (HP:0001998) | 1.98986670 |
89 | Abnormality of glycolysis (HP:0004366) | 1.98284286 |
90 | Opisthotonus (HP:0002179) | 1.96742498 |
91 | Hemorrhage of the eye (HP:0011885) | 1.96222380 |
92 | Hyperglycemia (HP:0003074) | 1.94321437 |
93 | Dicarboxylic aciduria (HP:0003215) | 1.89188801 |
94 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.89188801 |
95 | Pancreatitis (HP:0001733) | 1.88283378 |
96 | Back pain (HP:0003418) | 1.87238936 |
97 | Retinal atrophy (HP:0001105) | 1.86347132 |
98 | Increased serum ferritin (HP:0003281) | 1.85632426 |
99 | Brushfield spots (HP:0001088) | 1.85512119 |
100 | Vomiting (HP:0002013) | 1.85374102 |
101 | Abnormality of the gallbladder (HP:0005264) | 1.84831519 |
102 | Acanthocytosis (HP:0001927) | 1.82940662 |
103 | Cerebral palsy (HP:0100021) | 1.81638503 |
104 | Hypophosphatemic rickets (HP:0004912) | 1.80517720 |
105 | Symptomatic seizures (HP:0011145) | 1.78931441 |
106 | Status epilepticus (HP:0002133) | 1.78785364 |
107 | Rickets (HP:0002748) | 1.76292373 |
108 | Spastic paraparesis (HP:0002313) | 1.74129405 |
109 | Atrioventricular block (HP:0001678) | 1.71787362 |
110 | Enlarged kidneys (HP:0000105) | 1.69613077 |
111 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.68631008 |
112 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.68631008 |
113 | Axonal loss (HP:0003447) | 1.66571836 |
114 | Hypertriglyceridemia (HP:0002155) | 1.66360542 |
115 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.64009643 |
116 | Elevated alkaline phosphatase (HP:0003155) | 1.63328892 |
117 | Pulmonary embolism (HP:0002204) | 1.60385424 |
118 | Hyperphosphaturia (HP:0003109) | 1.59087378 |
119 | Osteomalacia (HP:0002749) | 1.57968659 |
120 | Insulin resistance (HP:0000855) | 1.56642207 |
121 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.56353120 |
122 | Fair hair (HP:0002286) | 1.49166324 |
123 | Abnormal platelet function (HP:0011869) | 1.47703417 |
124 | Impaired platelet aggregation (HP:0003540) | 1.47703417 |
125 | Glycosuria (HP:0003076) | 1.47175279 |
126 | Abnormality of urine glucose concentration (HP:0011016) | 1.47175279 |
127 | Abnormality of vitamin metabolism (HP:0100508) | 1.46291747 |
128 | Pigmentary retinal degeneration (HP:0001146) | 1.46157492 |
129 | Hyperalaninemia (HP:0003348) | 1.46108833 |
130 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.46108833 |
131 | Abnormality of alanine metabolism (HP:0010916) | 1.46108833 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 6.85841892 |
2 | BCKDK | 5.24397025 |
3 | FGFR4 | 4.96886980 |
4 | ERBB4 | 3.74437425 |
5 | SIK1 | 3.31542361 |
6 | TAOK3 | 3.00259065 |
7 | LMTK2 | 2.73544340 |
8 | DAPK2 | 2.62246765 |
9 | PINK1 | 2.49852218 |
10 | EPHA3 | 2.47147766 |
11 | EPHB1 | 2.33012387 |
12 | TRIB3 | 2.28348997 |
13 | ARAF | 2.26755269 |
14 | MAPKAPK3 | 2.21204929 |
15 | MST1R | 2.15995040 |
16 | INSRR | 2.13367132 |
17 | PTK6 | 2.01152303 |
18 | MAP2K4 | 1.99446113 |
19 | MAPK11 | 1.89161727 |
20 | MYLK | 1.82520338 |
21 | PIK3CG | 1.76106343 |
22 | TYK2 | 1.68944822 |
23 | PIK3CA | 1.66863258 |
24 | EPHB2 | 1.66072079 |
25 | MOS | 1.62935842 |
26 | RIPK1 | 1.55005493 |
27 | LATS1 | 1.52758173 |
28 | TRPM7 | 1.48556225 |
29 | JAK2 | 1.46772221 |
30 | NEK9 | 1.44152645 |
31 | ERBB2 | 1.34323381 |
32 | ADRBK1 | 1.28630548 |
33 | PKN2 | 1.27603936 |
34 | GRK5 | 1.26045755 |
35 | CAMKK2 | 1.23214196 |
36 | JAK1 | 1.19668098 |
37 | DDR2 | 1.19440230 |
38 | EEF2K | 1.17487553 |
39 | MAP3K7 | 1.10715789 |
40 | FRK | 1.10019452 |
41 | TESK1 | 1.09343799 |
42 | GRK6 | 1.08131497 |
43 | STK39 | 1.05681662 |
44 | ABL2 | 1.03453263 |
45 | TBK1 | 1.02156637 |
46 | MET | 1.00341785 |
47 | CAMK2G | 0.94831189 |
48 | GRK1 | 0.94742394 |
49 | MAP3K9 | 0.92691311 |
50 | STK38 | 0.92639405 |
51 | CAMK1D | 0.91855172 |
52 | TNK2 | 0.91367696 |
53 | MAP3K14 | 0.89805588 |
54 | MAP3K11 | 0.88495894 |
55 | MST4 | 0.86273763 |
56 | PKN1 | 0.82821496 |
57 | MAP3K12 | 0.82620313 |
58 | FLT3 | 0.80378580 |
59 | BRSK2 | 0.79704320 |
60 | PRKAA2 | 0.78212988 |
61 | FGFR2 | 0.77029121 |
62 | MAP3K3 | 0.73935685 |
63 | GRK7 | 0.73620225 |
64 | MAP2K1 | 0.73002616 |
65 | MAPK4 | 0.72624127 |
66 | FGFR3 | 0.72598261 |
67 | PRKCZ | 0.71841512 |
68 | MAPK12 | 0.71392481 |
69 | PRKACG | 0.67768690 |
70 | KDR | 0.66648865 |
71 | MAP2K3 | 0.65987246 |
72 | EPHA2 | 0.64460381 |
73 | PRKG1 | 0.63056656 |
74 | RET | 0.62190078 |
75 | OBSCN | 0.59377617 |
76 | PTK2 | 0.58946904 |
77 | GSK3A | 0.58469966 |
78 | MAP3K1 | 0.58179513 |
79 | FER | 0.57434680 |
80 | MAPK15 | 0.56213451 |
81 | CAMK1G | 0.53000794 |
82 | DYRK1B | 0.52881009 |
83 | BMX | 0.52822708 |
84 | HIPK2 | 0.52336161 |
85 | IRAK1 | 0.51693543 |
86 | CDK6 | 0.50707094 |
87 | PIM2 | 0.49289121 |
88 | CSK | 0.48957705 |
89 | LATS2 | 0.48214589 |
90 | NLK | 0.47368593 |
91 | EGFR | 0.47050420 |
92 | PDPK1 | 0.46997111 |
93 | PHKG1 | 0.45273317 |
94 | PHKG2 | 0.45273317 |
95 | IRAK3 | 0.44989888 |
96 | EPHA4 | 0.44786862 |
97 | PAK3 | 0.43009792 |
98 | TGFBR2 | 0.41531543 |
99 | CAMK1 | 0.41123155 |
100 | MTOR | 0.40699131 |
101 | IGF1R | 0.39962268 |
102 | PRKCE | 0.38448035 |
103 | CSF1R | 0.37562869 |
104 | IKBKE | 0.37305961 |
105 | MAP3K13 | 0.37253509 |
106 | NTRK1 | 0.36474543 |
107 | PRKACA | 0.36233912 |
108 | ILK | 0.36232511 |
109 | PRKCG | 0.35076139 |
110 | MAP3K10 | 0.34970432 |
111 | PRKAA1 | 0.34909803 |
112 | SGK3 | 0.33980366 |
113 | EIF2AK2 | 0.33167803 |
114 | MAP3K6 | 0.33038830 |
115 | CDC42BPA | 0.32951166 |
116 | MAPKAPK5 | 0.32393947 |
117 | ERBB3 | 0.32286042 |
118 | DAPK3 | 0.32259932 |
119 | MUSK | 0.32055753 |
120 | MAP2K6 | 0.31832416 |
121 | STK38L | 0.31350347 |
122 | ICK | 0.31044528 |
123 | PRKACB | 0.30421854 |
124 | NTRK3 | 0.30228747 |
125 | MAPK7 | 0.29422880 |
126 | ABL1 | 0.29391939 |
127 | BCR | 0.29120833 |
128 | PDGFRA | 0.28380514 |
129 | SGK223 | 0.28138934 |
130 | SGK494 | 0.28138934 |
131 | CAMK4 | 0.26589478 |
132 | KIT | 0.26443548 |
133 | TIE1 | 0.25747681 |
134 | PDK1 | 0.24589110 |
135 | DAPK1 | 0.23891333 |
136 | MAP3K5 | 0.23664014 |
137 | MAP3K2 | 0.23340275 |
138 | PRKCQ | 0.23000374 |
139 | KSR2 | 0.22603867 |
140 | CSNK1G1 | 0.22585641 |
141 | PRKCA | 0.22468729 |
142 | PRKCH | 0.20582360 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.71200156 |
2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.86841823 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.59317670 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.13921824 |
5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.13573799 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.85035654 |
7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.61152047 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.58881562 |
9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.51135997 |
10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.48127869 |
11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.45837630 |
12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.28302891 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.23806848 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.08974464 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08344373 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.07770907 |
17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95034013 |
18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93354602 |
19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86296583 |
20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.81560657 |
21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.79247712 |
22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74498821 |
23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.72546763 |
24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67194034 |
25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64634924 |
26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64292355 |
27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64015711 |
28 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56420235 |
29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53224238 |
30 | Bile secretion_Homo sapiens_hsa04976 | 1.50129042 |
31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47321575 |
32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.43976087 |
33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43601705 |
34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41804531 |
35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40383585 |
36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.39167134 |
37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.37478093 |
38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.37150997 |
39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.32980350 |
40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.29352396 |
41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27986074 |
42 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.27723678 |
43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.24681104 |
44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.24203174 |
45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21005751 |
46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17773913 |
47 | ABC transporters_Homo sapiens_hsa02010 | 1.14853685 |
48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13790604 |
49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10895866 |
50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09373104 |
51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06411250 |
52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05853280 |
53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99402596 |
54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95427548 |
55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93684092 |
56 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93675045 |
57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92575572 |
58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87478849 |
59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.85611789 |
60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84895387 |
61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82904234 |
62 | Prion diseases_Homo sapiens_hsa05020 | 0.82632952 |
63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79472713 |
64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70090730 |
65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67902994 |
66 | Lysine degradation_Homo sapiens_hsa00310 | 0.63954355 |
67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57517777 |
68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52465422 |
69 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51126695 |
70 | Mineral absorption_Homo sapiens_hsa04978 | 0.46232639 |
71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40851222 |
72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39305883 |
73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38463133 |
74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31391643 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30218169 |
76 | Insulin resistance_Homo sapiens_hsa04931 | 0.30205298 |
77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19763875 |
78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16977987 |
79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14188234 |
80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.08795527 |
81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.07493408 |
82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.04613219 |
83 | Bladder cancer_Homo sapiens_hsa05219 | 0.04309845 |
84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03648772 |
85 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03448943 |
86 | Hepatitis C_Homo sapiens_hsa05160 | 0.02585617 |
87 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2331559 |
88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.2111662 |
89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.2063421 |
90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2027563 |
91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1947511 |
92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.1922289 |
93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.1594989 |
94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1501927 |
95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1318785 |
96 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1263564 |
97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1216088 |
98 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1112415 |
99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0900781 |
100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0887766 |
101 | Pertussis_Homo sapiens_hsa05133 | -0.0883032 |
102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0782585 |
103 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0762777 |
104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0687421 |
105 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0671978 |
106 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0651742 |
107 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0369369 |
108 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0170645 |
109 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0134790 |
110 | Amoebiasis_Homo sapiens_hsa05146 | -0.0113955 |